COVID-19: Pfizer says demand for vaccine could be long-lasting like flu jab

US drugs giant Pfizer has said demand for its COVID-19 vaccine could become "durable" like flu jabs as it reported revenues of $3.5bn for the drug in the first quarter.

The full article is no longer available.